Home

SURENDRA K AJJARAPU

CIK 1368298 · Chairman and CEO · last filed 2026-06-25

SURENDRA K AJJARAPU is a Chairman and CEO who has filed 21 SEC Form 4 insider transactions across 5 companies since 2020. The most recent filing shows the insider was granted $1.0M of WGRX on Jun 25, 2026. Across all open-market trades the lifetime net is +$130.0M, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $105.8K across reported positions. 3 SEC filings were submitted jointly with Aesther Healthcare Sponsor, LLC.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$105.8K

Companies

5

Total Filings

21

Lifetime Open-Market Net

$130.01M

Filer Profile

Reported Address
8604 BUTTON BUSH CT
TAMPA, FL 33647
Related Filers
Aesther Healthcare Sponsor, LLC — 3 joint filings, latest 2023-03-24
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
Wellgistics Health, Inc. (WGRX) Delisted Director 7,971,511 $3.52 $28.06M $0 4 2026-06-25
MEDS Chairman and CEO 117,487 $0.90 $105.8K $130.01M 7 2024-05-28
Tevogen Bio Holdings Inc. (LGSTW) Delisted CEO and Chairman 8,988,889 $0.06 $540.2K $0 2 2023-06-21
Ocean Biomedical, Inc. (OCEAW) Delisted Director 258,200 $0.03 $7.7K $0 2 2023-03-24
Ocean Biomedical, Inc. (AEHAW) Delisted Chief Executive Officer — $0.16 — $0 1 2021-12-16

Recent Filings

21 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-06-25 Wellgistics Health, Inc. (WGRX) Delisted Grant (A) +5,000,000 $1.00M EDGAR
2026-06-25 Wellgistics Health, Inc. (WGRX) Delisted Exer (X) +100,000 $500 EDGAR
2026-04-23 Wellgistics Health, Inc. (WGRX) Delisted Grant (A) +5,000,000 $1.00M EDGAR
2025-03-25 Wellgistics Health, Inc. (WGRX) Delisted Grant (A) +4,082,247 $0 EDGAR
2024-05-28 MEDS Grant (A) +10,000 $0 EDGAR
2024-01-16 MEDS Grant (A) +150,000 $0 EDGAR
2023-06-21 Tevogen Bio Holdings Inc. (LGSTW) Delisted Grant (A) +7,988,889 $0 EDGAR
2023-06-12 Tevogen Bio Holdings Inc. (LGSTW) Delisted Grant (A) +1,000,000 $0 EDGAR
2023-03-24 Ocean Biomedical, Inc. (OCEAW) Delisted Other (J) −1,050,000 $0 EDGAR
2023-03-02 Ocean Biomedical, Inc. (OCEAW) Delisted Mixed −3,795,000 $0 EDGAR
Showing 1–10 of 21
Page 1 of 3
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.